Ciurea, Stefan O. http://orcid.org/0000-0001-8597-3271
Kongtim, Piyanuch
Soebbing, Doris
Trikha, Prashant
Behbehani, Gregory
Rondon, Gabriela
Olson, Amanda http://orcid.org/0000-0002-1669-0355
Bashir, Qaiser http://orcid.org/0000-0002-4086-6453
Gulbis, Alison M.
Indreshpal, Kaur
Rezvani, Katayoun
Shpall, Elizabeth J.
Bassett, Roland
Cao, Kai
Martin, Andrew St
Devine, Steven http://orcid.org/0000-0001-7731-759X
Horowitz, Mary
Pasquini, Marcelo
Lee, Dean A.
Champlin, Richard E. http://orcid.org/0000-0002-4314-5037
Article History
Received: 29 April 2021
Revised: 2 July 2021
Accepted: 12 July 2021
First Online: 26 July 2021
Competing interests
: SOC served as advisory board member for Cellularity, CareDx, Kiadis, Spectrum, CytoSen, MolMed, received research funds from Miltenyi Biotech and Kiadis, and has intellectual property and equity in Kiadis. PK served as advisory board member for CareDx. PT has intellectual property licensing to Kiadis Pharma. DAL received consulting fees, equity, and intellectual property in Kiadis Pharma. Consulting fees and equity in Courier Therapeutics, Consulting fees for Caribou Biosciences. All other authors had no potential conflict of interest to declare.